Literature DB >> 15963835

The molecular physiology and pathology of fibrin structure/function.

Kristina F Standeven1, Robert A S Ariëns, Peter J Grant.   

Abstract

The formation of a fibrin clot is a pivotal event in atherothrombotic vascular disease and there is mounting evidence that the structure of clots is of importance in the development of disease. This review describes the crucial events in the formation and dissolution of a clot, with particular focus on genetic and environmental factors that have been identified as determinants of fibrin structure in vivo, and discusses the substantiation of the relationship between fibrin structure and disease in conjunction with a review of the current literature.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15963835     DOI: 10.1016/j.blre.2005.01.003

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  29 in total

1.  Structural hierarchy governs fibrin gel mechanics.

Authors:  Izabela K Piechocka; Rommel G Bacabac; Max Potters; Fred C Mackintosh; Gijsje H Koenderink
Journal:  Biophys J       Date:  2010-05-19       Impact factor: 4.033

Review 2.  Mesenchymal stem cells: Mechanisms of immunomodulation and homing.

Authors:  Hiroshi Yagi; Alejandro Soto-Gutierrez; Biju Parekkadan; Yuko Kitagawa; Ronald G Tompkins; Naoya Kobayashi; Martin L Yarmush
Journal:  Cell Transplant       Date:  2010-06-03       Impact factor: 4.064

3.  Molecular mechanisms, thermodynamics, and dissociation kinetics of knob-hole interactions in fibrin.

Authors:  Olga Kononova; Rustem I Litvinov; Artem Zhmurov; Andrey Alekseenko; Chia Ho Cheng; Silvi Agarwal; Kenneth A Marx; John W Weisel; Valeri Barsegov
Journal:  J Biol Chem       Date:  2013-05-28       Impact factor: 5.157

4.  Fibrinogen regulates the cytotoxicity of mycobacterial trehalose dimycolate but is not required for cell recruitment, cytokine response, or control of mycobacterial infection.

Authors:  Kaori Sakamoto; Rachel E Geisel; Mi-Jeong Kim; Bryce T Wyatt; Llewelyn B Sellers; Stephen T Smiley; Andrea M Cooper; David G Russell; Elizabeth R Rhoades
Journal:  Infect Immun       Date:  2009-12-22       Impact factor: 3.441

5.  Evaluating factor XIII specificity for glutamine-containing substrates using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry assay.

Authors:  Prakash G Doiphode; Marina V Malovichko; Kelly Njine Mouapi; Muriel C Maurer
Journal:  Anal Biochem       Date:  2014-04-19       Impact factor: 3.365

6.  A novel fibrinogen variant: dysfibrinogenemia associated with γAsp185Asn substitution.

Authors:  Na Zhou; Peipei Xu; Min Zhou; Yong Xu; Ping Li; Bin Chen; Jian Ouyang; Rongfu Zhou
Journal:  J Thromb Thrombolysis       Date:  2017-07       Impact factor: 2.300

7.  Bromelain and cardiovascular risk factors in diabetes: An exploratory randomized, placebo controlled, double blind clinical trial.

Authors:  Chit Moy Ley; Qing Ni; Xing Liao; Huai-Lin Gao; Nicola Robinson
Journal:  Chin J Integr Med       Date:  2016-07-13       Impact factor: 1.978

8.  Evaluating the Effects of Fibrinogen αC Mutations on the Ability of Factor XIII to Crosslink the Reactive αC Glutamines (Q237, Q328, Q366).

Authors:  Kelly Njine Mouapi; Lucille J Wagner; Chad A Stephens; Mohammed M Hindi; Daniel W Wilkey; Michael L Merchant; Muriel C Maurer
Journal:  Thromb Haemost       Date:  2019-05-05       Impact factor: 5.249

9.  Ranking reactive glutamines in the fibrinogen αC region that are targeted by blood coagulant factor XIII.

Authors:  Kelly Njine Mouapi; Jacob D Bell; Kerrie A Smith; Robert A S Ariëns; Helen Philippou; Muriel C Maurer
Journal:  Blood       Date:  2016-03-07       Impact factor: 22.113

10.  Macrophage embedded fibrin gels: an in vitro platform for assessing inflammation effects on implantable glucose sensors.

Authors:  Matthew T Novak; Fan Yuan; William M Reichert
Journal:  Biomaterials       Date:  2014-08-28       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.